Health / Health News

    Can't Sleep? Could Be Down to Genetics

    Researchers of the University of California San Diego have identified specific genes that may trigger the development of sleep problems, and have also demonstrated a genetic link between insomnia and psychiatric disorders such as depression, or physical conditions such as type 2 diabetes.



    Specific genes may trigger the development of sleep problems.


    The effects insomnia has on a person's health can be debilitating and place a strain on the healthcare system.

    Chronic insomnia goes hand in hand with various long-term health issues such as heart disease and type 2 diabetes, as well as mental illness such as post-traumatic stress disorder (PTSD) and suicide.

    Twin studies have in the past shown that various sleep-related traits, including insomnia, are heritable. Based on these findings, researchers have started to look into the specific gene variants involved.

    The study confirms that insomnia has a partially heritable basis. The researchers also found a strong genetic link between insomnia and type 2 diabetes.

    Among participants of European descent, there was additionally a genetic tie between sleeplessness and major depression.

    Insomnia was linked to the occurrence of specific variants on chromosome 7. In people of European descent, there were also differences on chromosome 9.

    The variant on chromosome 7, for instance, is close to AUTS2, a gene that has been linked to alcohol consumption, as well as others that relate to brain development and sleep-related electric signaling.

    Several of these variants rest comfortably among locations and pathways already known to be related to sleep and circadian rhythms. Such insomnia associated loci may contribute to the genetic risk underlying a range of health conditions including psychiatric disorders and metabolic disease. (Tasnim News Agency)

    MARCH 12, 2018



    YOU MAY ALSO LIKE

    An ingredient commonly found in toothpaste could be employed as an anti-malarial drug against strains of malaria parasite that have grown resistant to one of the currently-used drugs. This discovery, led by researchers at the University of Cambridge, was aided by Eve, an artificially-intelligent ‘robot scientist’.
    Children living with HIV in Brazil are to benefit from the introduction of a new medicine manufactured with groundbreaking technology.
    Combining a 16-week initial course of the medication omalizumab with oral immunotherapy (OIT) greatly improves the efficacy of OIT for children with allergies to multiple foods, new clinical trial findings show.
    A new study found that daily aspirin therapy was significantly associated with a reduced risk in hepatitis B related liver cancer.
    Drinking coffee was associated with lower risk of death due to heart disease, cancer, stroke, diabetes, and kidney disease.
    Regular chocolate consumption may be linked to a lower risk of developing the heart rhythm irregularity atrial fibrillation, also known as heart flutter.

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact